Oldest pages

Showing below up to 50 results in range #71 to #120.

View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)

71. 4.3.1.1 Adding new items‏‎ (19:20, 5 September 2020)
72. ARRIVE 2.0‏‎ (09:36, 29 September 2020)
73. 3.4.1 Animal characteristics, care and use‏‎ (10:15, 29 September 2020)
74. 3.4.1.1 Ethical evaluation and authorization process of animal use‏‎ (09:22, 1 October 2020)
75. PREPARE‏‎ (14:42, 2 October 2020)
76. 4.2.3 Responsible conduct of research‏‎ (15:36, 3 November 2020)
77. 3.1.3 Data security‏‎ (08:18, 9 November 2020)
78. 3.4.2.2 Antibody validation‏‎ (12:07, 24 November 2020)
79. 3.2.4 Training on specific methods, tasks and activities‏‎ (10:45, 8 December 2020)
80. 3.4.2.3 Biological and technical replicates‏‎ (16:48, 3 February 2021)
81. 3.1.2 Procedures for how and when to record data‏‎ (09:01, 12 February 2021)
82. 1.3.1 Transparency‏‎ (10:21, 15 February 2021)
83. 1.5.1 Quality policy‏‎ (10:23, 15 February 2021)
84. 1.5.2.3 Process owner‏‎ (10:24, 15 February 2021)
85. 1.5.4 Prevention of Conflict of Interest‏‎ (10:25, 15 February 2021)
86. 3.1.2.2 Process for witnessing of records‏‎ (10:29, 15 February 2021)
87. 4.3.1.2 Deleting items‏‎ (09:53, 22 February 2021)
88. 2.1.8 Randomisation‏‎ (07:34, 4 March 2021)
89. 2.3.1.1 Converting non-electronic information into an electronic form‏‎ (09:31, 10 March 2021)
90. EQIPD principles‏‎ (09:14, 16 March 2021)
91. Performance Standards‏‎ (09:18, 18 March 2021)
92. FAQ‏‎ (19:40, 23 March 2021)
93. 2.3.4 Data visualization‏‎ (19:41, 23 March 2021)
94. 2.3.3 Statistical analysis‏‎ (19:41, 23 March 2021)
95. 2.1.10 Plausibility check‏‎ (19:43, 23 March 2021)
96. 2.1.7 Blinding‏‎ (19:43, 23 March 2021)
97. 1.5.2.7 Quality professionals‏‎ (19:46, 23 March 2021)
98. 1.5.2.5 Research team‏‎ (19:47, 23 March 2021)
99. 2.1.3 Appraisal of literature and systematic reviews‏‎ (12:43, 24 March 2021)
100. 2.1.9 Inclusion and exclusion criteria‏‎ (12:46, 24 March 2021)
101. 2.4 Reporting‏‎ (12:47, 24 March 2021)
102. 1.5.2.4 Principal investigators and study directors‏‎ (12:54, 24 March 2021)
103. ARRIVE Essential - Outcome measures‏‎ (13:02, 24 March 2021)
104. 2.1.5 Pre-specification‏‎ (13:03, 24 March 2021)
105. 1.4.3 Quality in collaborative research‏‎ (06:38, 25 March 2021)
106. 4.3.2 Using the EQIPD applications‏‎ (16:51, 29 March 2021)
107. 4.3.2.2 Creating NEEDs‏‎ (16:53, 29 March 2021)
108. 4.3.2.3 Revising NEEDs‏‎ (12:47, 31 March 2021)
109. 1.1 Mission‏‎ (16:04, 7 April 2021)
110. 1.5.2 Roles and responsibilities of involved personnel and organization‏‎ (09:23, 9 April 2021)
111. EQIPD for Core Facilities‏‎ (12:39, 15 April 2021)
112. 2.3.2 Primary analysis and evaluation of raw data‏‎ (13:17, 15 April 2021)
113. 2.2.3 Documentation of the experiment and deviations‏‎ (13:27, 15 April 2021)
114. 1.2 Scope‏‎ (06:44, 20 April 2021)
115. 2.1.2 Unique study ID‏‎ (07:51, 28 April 2021)
116. Examples of implementing a unique study ID‏‎ (07:51, 29 April 2021)
117. Documentation in EQIPD‏‎ (08:49, 6 May 2021)
118. 1.4.2 Adherence to legal and regulatory considerations‏‎ (06:45, 7 May 2021)
119. Core Requirements‏‎ (17:55, 10 May 2021)
120. Experimental Record‏‎ (18:22, 10 May 2021)

View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)